Director of the Clinical Research Proteomics Platform, Brotman Baty Institute, Seattle, Washington, United States
Dr. Paulovich received her M.D. and Ph.D. at the University of Washington. She completed residency in Internal Medicine at Massachusetts General Hospital and a fellowship in Oncology at Dana-Farber Cancer Center in Boston. Her postdoctoral training was at MIT-Whitehead Center for Genomics Research with Dr. Eric Lander. As an oncologist, she was struck by the paucity of quantitative assays for measuring clinical phenotypes in her patients, and the limitations that this put on her ability to practice “personalized medicine.” Out of these experiences, she became passionate about developing technologies and strategies for translation of novel diagnostics and therapeutics to enable precision medicine. Over the past 17 years, Dr. Paulovich's research has focused on relieving a roadblock in biomedical research: a lack of validated and standardized tools for quantifying human proteins. She was inducted to American Society for Clinical Investigation, received the 2014 Life Science Innovation Northwest Women to Watch in Life Science Award, received the 2015 Distinguished Achievement in Proteomic Sciences Award from HUPO, was awarded the Aven Foundation Endowed Chair in 2018, and was appointed Director of the Clinical Research Proteomics Platform of the Brotman Baty Institute for Precision Medicine in 2019.
